drugset / Trial / NCT02260063
Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To assess the bioequivalence of two galenic formulations for epinastine (Flurinol®): syrup and 20 mg tablets
Timeline
- Start
- 1998-11
- Primary completion
- 1999-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Epinastine | Small molecule | 20 mg | — |
Indications
No indication recorded.